CHICAGO – The University of Chicago swimming and diving teams will participate in the 13th-annual Ted Mullin "Leave it in the Pool – Hour of Power" Relay for Sarcoma Research beginning at 4:00 PM on Tuesday, Nov. 13.
College, high school, and club teams from around the world will take part in the continuous relay, which involves any stroke, all-out swimming for an hour with the objective of keeping all lanes in each pool on the same length. Last year, over 8,650 athletes from 166 teams across the country and abroad participated.
The relay honors the memory of former Carleton College swimmer Ted Mullin, who passed away from synovial sarcoma in September 2006. The goals of the event are to raise awareness of sarcoma and generate funds for the University of Chicago's pediatric cancer program, which conducts research into finding treatment and cures for sarcoma. The Ted Mullin Fund has raised over $1.25 million for this effort, with the Hour of Power having contributed over 60 percent of that total.
The Ted Mullin Fund supports research into novel chemotherapy/biology agents for sarcomas, new ways to administer chemotherapy in this disease, techniques to visualize more accurately the tumor response in the patient, novel genomics strategies to identify high-risk sarcoma patients, molecular techniques to personalize therapy to maximize benefit while reducing treatment-related toxicity, and treatments for metastatic or resistant disease that use the patient's own immune system to attack residual tumors.
Each summer, University of Chicago Medicine (UCM) hosts Ted Mullin Fund Scholars in pediatric cancer laboratories, giving collegiate Ted Mullin "Hour of Power" participants an opportunity to advance their interest in science and cancer biology. With initial seed money from the Ted Mullin Fund, UCM is celebrating the fifth anniversary of the Adolescent and Young Adult Oncology Program. The Ted Mullin Fund also supports the UCM comprehensive Pediatric Cancer Data Commons that will collect standardized data from as many pediatric cancer patients as possible in one central repository and share it openly with the entire research community.